| Page 9 | Kisaco Research
 

Damon Gupta

Director, Patent Counsel
Spark Therapeutics, Inc

Damon Gupta is a Director, Patent Counsel at Spark Therapeutics, Inc., a leader in gene therapy and member of the Roche Group. With over a decade of experience in intellectual property (IP) law and a background in molecular biology, Damon advises biotechnology and pharmaceutical companies on patent strategy, IP transactions, and risk mitigation.

Read full bio

Damon Gupta

Director, Patent Counsel
Spark Therapeutics, Inc

Damon Gupta

Director, Patent Counsel
Spark Therapeutics, Inc

Damon Gupta is a Director, Patent Counsel at Spark Therapeutics, Inc., a leader in gene therapy and member of the Roche Group. With over a decade of experience in intellectual property (IP) law and a background in molecular biology, Damon advises biotechnology and pharmaceutical companies on patent strategy, IP transactions, and risk mitigation. At Spark, Damon leads efforts to protect proprietary assets, including trade secrets, manage IP disputes, and provides IP support to cross-functional teams, including R&D, manufacturing, and corporate transactions. Damon holds a J.D. from Chicago-Kent College of Law, an M.S. from Baylor College of Medicine, and a B.S. from The Ohio State University.

Author:

Gregory Bombard

Shareholder
Greenberg Traurig, LLP

Gregory S. Bombard is a trial lawyer whose practice focuses on trade secret litigation. Greg also handles other IP litigation and complex commercial disputes. His trade secret clients are primarily in high tech industries, including biotech, medical devices, software, robotics, fintech, and manufacturing. Greg is an author of the ABA’s Guide to Protecting and Litigating Trade Secrets, 2nd Ed., and co-chairs of the ABA’s Trade Secret Litigation Subcommittee. Greg is a shareholder in the Boston office of the international law firm Greenberg Traurig, LLP. He can be reached at [email protected]. 

... read more

Gregory Bombard

Shareholder
Greenberg Traurig, LLP

Gregory S. Bombard is a trial lawyer whose practice focuses on trade secret litigation. Greg also handles other IP litigation and complex commercial disputes. His trade secret clients are primarily in high tech industries, including biotech, medical devices, software, robotics, fintech, and manufacturing. Greg is an author of the ABA’s Guide to Protecting and Litigating Trade Secrets, 2nd Ed., and co-chairs of the ABA’s Trade Secret Litigation Subcommittee. Greg is a shareholder in the Boston office of the international law firm Greenberg Traurig, LLP. He can be reached at [email protected]. 

Author:

John Lee

Chief Counsel for Intellectual Property
U.S. House of Representatives, Committee on the Judiciary
... read more

John Lee

Chief Counsel for Intellectual Property
U.S. House of Representatives, Committee on the Judiciary

Intellectual Property (IP) litigation, especially in patent and trade secret cases, can be a critical battleground for businesses trying to protect their innovations. Whether defending their rights or asserting them, companies
need to understand the strategic dynamics of offensive vs. defensive litigation.

- Understand the core differences between offensive and defensive litigation in patent and trade secret disputes.
- Learn the strategic advantages and risks of initiating litigation versus responding to a lawsuit.
- Explore the best practices for managing complex IP cases, including litigation timing, settlement negotiations, and strategic use of court motions.
- Gain insights into navigating the evolving landscape of patent and trade secret law, including challenges posed by technology and international jurisdiction
- Navigating Non practicing entity (NPE) Litigation scenarios

Author:

Lana Gladstein

General Counsel
Seaport Therapeutics

Lana Gladstein currently works as a General Counsel for Seaport Therapeutics. She previously worked at APRINOIA Therapeutics as a Group General Counsel. Lana Gladstein attended Northeastern University School of Law.

... read more

Lana Gladstein

General Counsel
Seaport Therapeutics

Lana Gladstein currently works as a General Counsel for Seaport Therapeutics. She previously worked at APRINOIA Therapeutics as a Group General Counsel. Lana Gladstein attended Northeastern University School of Law.

Author:

Brad Bidwell

Assistant General Counsel - IP and HR
Knowles Corporation
... read more

Brad Bidwell

Assistant General Counsel - IP and HR
Knowles Corporation